Jean-Claude M. Rwigema
Papers
2
Total Citations
64
H-Index
2
About
Jean-Claude M. Rwigema is a leading figure in radiation oncology, with a focused expertise in stereotactic body radiotherapy (SBRT) and its application to complex, high-risk malignancies. His seminal work, "Adjuvant Stereotactic Body Radiotherapy for Resected Pancreatic Adenocarcinoma with Close or Positive Margins" (2010, 57 citations), established a critical framework for improving local control in one of the most challenging cancers, demonstrating the feasibility and potential of SBRT in the postoperative setting. He has also advanced the field's understanding of SBRT for head and neck malignancies, exploring how technological innovations in robotics, imaging, and stereotactic localization can be harnessed to treat anatomically sensitive tumors with unprecedented precision. By pushing the boundaries of non-invasive, high-dose radiation delivery, Dr. Rwigema’s research directly addresses the need for more effective, targeted therapies that minimize damage to surrounding healthy tissue. His contributions continue to shape clinical protocols and inspire further investigation into the curative potential of stereotactic body radiotherapy.
Research Focus
Key Achievements
Top Papers
- 1
- 2